DSpace at RU >

Browsing by Author Schuurhuis, D.H.

Full Text	Issue Date	Title	Author(s)
	2012	Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients	Aarntzen, E.H.J.G.; Schreibelt, G.; Bol, K.F.; Lesterhuis, W.J.; Croockewit, A.J., et al
	2010	Immunogenicity of Dendritic Cells Pulsed with CEA Peptide or Transfected with CEA mRNA for Vaccination of Colorectal Cancer Patients.	Lesterhuis, W.J.; Vries, I.J.M. de; Schreibelt, G.; Schuurhuis, D.H.; Aarntzen, E.H.J.G., et al
	2009	Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells.	Schuurhuis, D.H.; Lesterhuis, W.J.; Kramer, M.; Looman, M.W.G.; Hout-Kuijer, M.A. van, et al
	2009	In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients.	Schuurhuis, D.H.; Verdijk, P.; Schreibelt, G.; Aarntzen, E.H.J.G.; Scharenborg, N.M., et al
	2008	Dendritic cell vaccines in melanoma: from promise to proof?	Lesterhuis, W.J.; Aarntzen, E.H.J.G.; Vries, I.J.M. de; Schuurhuis, D.H.; Figdor, C.G., et al
	2008	Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.	Boullart, A.C.; Aarntzen, E.H.J.G.; Verdijk, P.; Jacobs, J.F.; Schuurhuis, D.H., et al
	2006	Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests.	Lesterhuis, W.J.; Vries, I.J.M. de; Schuurhuis, D.H.; Boullart, A.C.I.; Jacobs, J.F.M., et al
	2006	Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests	Lesterhuis, W.J.; Vries, I.J.M. de; Schuurhuis, D.H.; Boullart, A.C.I.; Jacobs, J.F.M., et al
	2006	Ins and outs of dendritic cells.	Schuurhuis, D.H.; Fu, N.; Ossendorp, F.; Melief, C.J.
	2006	Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.	Jong, J.M.A.; Schuurhuis, D.H.; Ioan-Facsinay, A.; Welling, M.M.; Camps, M., et al
	2006	Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine.	Schuurhuis, D.H.; Montfoort, N. van; Ioan-Facsinay, A.; Jiawan, R.; Camps, M., et al
	2006	Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo.	Jong, J.M.A.; Schuurhuis, D.H.; Ioan-Facsinay, A.; Voort, E.I. van der; Huizinga, T.W.J., et al
	2005	Vaccination of colorectal cancer patients with carcincembryonic antigen peptide-loaded dendritic cells	Lesterhuis, W.J.; Vries, I.J.M. de; Schuurhuis, D.H.; Scharenborg, N.M.; Brouwer, M., et al
	2005	Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells.	Ossendorp, F.; Fu, N.; Camps, M.; Granucci, F.; Gobin, S.J.P., et al